Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 716
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07546500 ASPENOVA — A Study of Azenosertib (ZN-c3) Versus Investigator's Choice … |
Investigator's choice of Chemothe… | Cancer | Phase 3 | RECRUITING | En attente / non publié | K-Group, Beta, Inc., a wholly own… | United States, Argentina, Australia, Belgium, Brazil,… | 2026-04-17 → 2030-04-30 | Ouvrir |
| NCT07902921 STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic… |
STAR0602 | Parkinson | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-11-12 → 2030-06-30 | Ouvrir |
| NCT04299620 Micro-Ultrasound for the Detection and Localization of Prostate Cancer … |
Digital Image Analysis | Cancer | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Jonsson Comprehensive Cancer Cent… | United States · UCLA / Jonsson Comprehensive Cancer C… | 2020-10-21 → 2025-09-01 | Ouvrir |
| NCT02135419 ANCHOR — Treatment in Preventing Anal Cancer in Patients With HIV and A… |
imiquimod | Cancer | Phase 3 | COMPLETED | En attente / non publié | AIDS Malignancy Consortium | United States, Puerto Rico · ACC Clinic, Jackson Hosp… | 2014-09-24 → 2024-03-31 | Ouvrir |
| NCT02956239 DELTA — Development, Field Testing and Evaluation of the Efficacy of a … |
Thermocoagulation (device) | Cancer | Non applicable | COMPLETED | En attente / non publié | International Agency for Research… | Zambia · UNC Global Project Zambia, Lusaka, Zambia | 2017-08-01 → 2024-02-29 | Ouvrir |
| NCT03402607 Trial Comparing PLA to HIGRT (PROVE-HCC) |
Percutaneous Local Ablation | Cancer | Non applicable | TERMINATED | En attente / non publié | Duke University | United States · Duke Cancer Center, Durham, United St… | 2018-08-08 → 2020-03-25 | Ouvrir |
| NCT07799194 Percutaneous Pulsed Electric Field Ablation for Early-Stage NSCLC and L… |
Pulsed Electric Field Ablation | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Energenx Medical LTD. | China · The First Affiliated Hospital of Guagnzhou Me… | 2026-09 → 2028-06 | Ouvrir |
| NCT05132205 Radiofrequency Ablation of Papillary Thyroid Microcarcinoma |
Radiofrequency Ablation | Cancer | Non applicable | COMPLETED | En attente / non publié | Johns Hopkins University | United States · Johns Hopkins Hospital, Baltimore, Un… | 2021-12-17 → 2024-11-19 | Ouvrir |
| NCT07889297 Pulsed Field Ablation for the Treatment of Malignant Lung Tumors |
Pulsed Field Ablation System and … | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Shanghai Chest Hospital | China · Shanghai Chest hospital, Shanghai, China | 2026-10 → 2028-10 | Ouvrir |
| NCT05444361 Ultrasound-Guided Percutaneous Cryoneurolysis to Treat Postoperative Pa… |
Cryoneurolysis | Cancer | Non applicable | ENROLLING_BY_INVITATION | En attente / non publié | Oxford University Hospitals NHS T… | United States · Cedars-Sinai, Los Angeles, United Sta… | 2022-09-15 → 2028-06-30 | Ouvrir |
| NCT04794660 CESTA — The Study for the "Cervical Cancer Screening and Treatment Algo… |
Treatment by ablative treatment | Cancer | Phase 3 | UNKNOWN | En attente / non publié | International Agency for Research… | Senegal, South Africa · Frere Hospital, East London, … | 2019-10-01 → 2025-10-01 | Ouvrir |
| NCT05438563 MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment… |
MRI-Guided Transurethral Ultrasou… | Cancer | Non applicable | RECRUITING | En attente / non publié | Mayo Clinic | United States · Mayo Clinic in Rochester, Rochester, … | 2022-04-06 → 2028-12-07 | Ouvrir |
| NCT03741088 Study to Evaluate VORTX Rx (Theresa) |
VORTX Rx treatment | Cancer | Non applicable | COMPLETED | En attente / non publié | HistoSonics, Inc. | Spain · Clinica Diagonal, Esplugues de Llobregat, Spa… | 2018-03-21 → 2019-07-17 | Ouvrir |
| NCT05862285 UmbrellaMAX — A Rollover Study for Participants Previously Enrolled in … |
Ipatasertib | Cancer | Phase 3 | RECRUITING | En attente / non publié | Hoffmann-La Roche | Belgium, Canada, China, Costa Rica, France, Greece, J… | 2023-06-01 → 2033-03-01 | Ouvrir |
| NCT07029646 Comparative Research on the Accuracy of Margin Interpretation in Breast… |
EndoScell™ intraoperative handhel… | Cancer | Non applicable | COMPLETED | En attente / non publié | Peking University Cancer Hospital… | China · Peking University Cancer Hospital & Institute… | 2025-07-01 → 2026-08-31 | Ouvrir |
| NCT06993675 Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing… |
Talquetamab | Cancer | Phase 2 | RECRUITING | En attente / non publié | Noffar Bar | United States · University of Nebraska Medical Center… | 2025-08-21 → 2029-08 | Ouvrir |
| NCT05693766 INSIGHT — Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort |
Capecitabine | Cancer | Phase 2 | RECRUITING | En attente / non publié | Sonya Reid | United States · University of Alabama Birmingham, Bir… | 2023-09-28 → 2037-08-31 | Ouvrir |
| NCT07695740 Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma |
YKST02 | Cancer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Excyte Biopharma Ltd | China · Beijing Chao-Yang Hospital, Capital Medical U… | 2027-12 → 2030-12 | Ouvrir |
| NCT04586231 A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus C… |
Belzutifan | Cancer | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Austria, Belgium… | 2021-02-25 → 2027-02-11 | Ouvrir |
| NCT07237594 IL-17 Blockade to Decrease irAEs (REPLAY) |
Secukinumab Injection | Cancer | Phase 1 | RECRUITING | En attente / non publié | Duke University | United States · Duke University Health System, Durham… | 2026-03-12 → 2030-06-30 | Ouvrir |
| NCT07922967 PRORADNOR-ReIR — Proton Re-irradiation in Patients With Recurrent or Se… |
Proton radiotherapy | Cancer | À vérifier | RECRUITING | En attente / non publié | Oslo University Hospital | Norway · Haukeland University Hospital, Bergen, Norwa… | 2026-11-20 → 2045-06-20 | Ouvrir |
| NCT04198766 Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Key… |
INBRX-106 - Hexavalent OX40 agoni… | Cancer | Phase 1/2 | RECRUITING | En attente / non publié | Inhibrx Biosciences, Inc | United States, Singapore, South Korea, Taiwan · Ajou … | 2019-12-10 → 2033-07 | Ouvrir |
| NCT07902375 MYSSELF — Methylation Profiling in Self-Samples for Identification of (… |
Colli-Pee 20 mL device with UCM | Cancer | Non applicable | RECRUITING | En attente / non publié | Universiteit Antwerpen | Belgium · University Hospital of Antwerp (UZA), Edege… | 2026-06-19 → 2032-12-31 | Ouvrir |
| NCT07920731 A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line… |
imotuzumab combined with the NALI… | Cancer | Phase 2 | ENROLLING_BY_INVITATION | En attente / non publié | Fudan University | China · FUSCC, Shanghai, China | 2026-06-06 → 2028-08-10 | Ouvrir |
| NCT01089101 Selumetinib in Treating Young Patients With Recurrent or Refractory Low… |
Biospecimen Collection | Cancer | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Roswell Park Cancer Institute | United States · Baylor College of Medicine/Dan L Dunc… | 2010-07-07 → 2027-03-18 | Ouvrir |